Gram Positive Bacteria | The Truth About Skin Care

{ Tag Archives } Gram Positive Bacteria

Lytix Biopharma AS Announces Approval By Hungarian Authorities To Start Phase IIa Clinical Trial With LytixarTM In Gram Positive Skin Infections

Main Category: Dermatology
Also Included In: Clinical Trials / Drug Trials; Infectious Diseases / Bacteria / Viruses
Article Date: 01 Sep 2010 – 6:00 PDT

email to a friend printer friendly opinions
<!– rate article
The Norwegian pharmaceutical company Lytix Biopharma AS today announces the approval in Hungary to commence a Phase IIa [...]

Also tagged Biopharma, Broad Spectrum, Clinical Trial, Clinical Trials, Cross Resistance, Drug Resistant Bacteria, Gunnar, Hungarian Authorities, Infectious Diseases, Mechanism Of Action, Novel Drug, Patient Group, Pharmaceutical Company, Phase Iia, Rate Article, Regulatory Authorities, Resistant Staphylococcus Aureus, Skin Bacteria, Skin Infections

2010 09 01 Skin Care News Comments Off

European CHMP Concludes Re-examination Of Ceftobiprole

Main Category: Infectious Diseases / Bacteria / Viruses
Also Included In: Dermatology; Regulatory Affairs / Drug Approvals
Article Date: 27 Jun 2010 – 0:00 PDT

email to a friend printer friendly view / write opinions
<!– rate article

Basilea Pharmaceutica Ltd. (SWISS: BSLN) announces that following a request for re-examination from the Applicant Janssen-Cilag [...]

Also tagged Authorization Application, Broad Spectrum, Ceftobiprole, Chmp, Drug Approvals, Friendly View, Good Clinical Practice, Gram Negative Bacteria, Infectious Diseases, International Nv, Janssen Cilag, Pharmaceutica, Pseudomonas, Rate Article, Regulatory Affairs, Resistant Staphylococcus Aureus, Soft Tissue Infections, Streptococcus Pneumonia, Superbug

2010 06 27 Skin Care News Comments Off

Theravance And Astellas Announce The Commercial Launch Of VIBATIVTM (telavancin) In The United States

Theravance, Inc. (NASDAQ: THRX) and Astellas Pharma US, Inc. announced today the commercial launch of VIBATIV™ (telavancin) in the United States. On September 11, 2009, the U.S. Food and Drug Administration (FDA) approved VIBATIV for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria, including Staphylococcus [...]

Also tagged Adult Patients, Astellas Pharma Us, Astellas Pharma Us Inc, Fda, Food And Drug, Food And Drug Administration, Food And Drug Administration Fda, Launch, Mrsa, Nasdaq, September 11, Skin And Skin, Skin Structure Infections, Staphylococcus Aureus, Strains, Telavancin, Theravance Inc, Thrx, United States

2009 11 06 Skin Care News Comments Off

Theravance And Astellas Announce FDA Approval Of VIBATIVTM (telavancin) For The Treatment Of Complicated Skin And Skin Structure Infections

Theravance, Inc. (NASDAQ: THRX) and Astellas Pharma US, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved VIBATIV™ (telavancin) for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria, including Staphylococcus aureus, both methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) strains.

Also tagged Adult Patients, Astellas Pharma Us, Astellas Pharma Us Inc, Fda, Fda Approval, Fda Approved, Food And Drug, Food And Drug Administration, Food And Drug Administration Fda, Mrsa, Nasdaq, Skin And Skin, Skin Infections, Skin Structure Infections, Staphylococcus Aureus, Strains, Telavancin, Theravance Inc, Thrx

2009 09 14 Skin Care News Comments Off

The Truth About Skin Care

{ Tag Archives } Gram Positive Bacteria

Lytix Biopharma AS Announces Approval By Hungarian Authorities To Start Phase IIa Clinical Trial With LytixarTM In Gram Positive Skin Infections

European CHMP Concludes Re-examination Of Ceftobiprole

Theravance And Astellas Announce The Commercial Launch Of VIBATIVTM (telavancin) In The United States

Theravance And Astellas Announce FDA Approval Of VIBATIVTM (telavancin) For The Treatment Of Complicated Skin And Skin Structure Infections

Home

Recommendations

Free Ebook

Latest News

Site Features

Get a free ebook valued at $8.95 when you sign up for our free Skincare Tips newsletter. The book The Truth About Skincare: How To Have Younger Looking Skin sells every day for $8.95 at Bargain Books Web. It's yours at no cost by immediate download when you sign up right now. You can unsubscribe any time, and the book is yours to keep.
Name:
Email: